""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent_original"	"response_agent"	"proterm_and_extra"	"fully_qualified_response_agent"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"comments"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subObsID"	"uniqObsID"	"signature_file"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"file"
"role"	""	""	""	"tissue"	"observed"	"cell_biomarker"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (original)"	"response agent (cell subset)"	"cell type PRO and extra terms"	"all response agents in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"target pathogen"	"vaccine year"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"figure or table or text section containing signature"	"comments and additional details"	"Rechtien et al. (2018) Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. Cell Rep PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=28854372' target='_blank'>28854372</a>"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"signature response agents file"
""	"20180430-hipciof_ctf_corr_28854372"	"2018.04.30"	"hipciof_ctf_corr_4"	"peripheral blood mononuclear cell"	"CD16-negative, CD56-bright natural killer cell"	"CD16-negative, CD56-bright natural killer cell"	""	"CD16-negative, CD56-bright natural killer cell"	"cell type frequency"	"positively"	"none"	"3"	"Days"	"ebola virus"	""	"rVSV-EBOV"	"VO_0004660"	""	"correlated with antibody response at 28d and onward"	"time of vaccination (first dose)"	"adults (18-55)"	"28854372"	"2017"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=28854372"	"adults"	"18"	"55"	"years"	"1"	"17"	"hipciof_ctf_corr_28854372_17.txt"
